Immune-related adverse events and the balancing act of immunotherapy COMMENT

被引：182

作者：

Conroy, Michael ^{[1
,2
,3
]}

Naidoo, Jarushka ^{[1
,2
,3
,4
]}

机构：

[1] Beaumont RCSI Canc Ctr, Dublin, Ireland

[2] Beaumont Hosp, Dublin, Ireland

[3] RCSI Univ Hlth Sci, Dublin, Ireland

[4] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA

来源：

NATURE COMMUNICATIONS | 2022年 / 13卷 / 01期

关键词：

PNEUMONITIS;

D O I：

10.1038/s41467-022-27960-2

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The benefit from immune checkpoint inhibitors is tempered by immunologic toxicities, which involve diverse organs, have varying biology, onset time, and severity. Herein, we identify important areas of controversy and open research questions in the field of immune-related toxicity.

引用

页数：4

共 20 条

[11] Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, Bertrand
Le Chatelier, Emmanuelle
Derosa, Lisa
Duong, Connie P. M.
Alou, Maryam Tidjani
Daillere, Romain
Fluckiger, Aurelie
Messaoudene, Meriem
Rauber, Conrad
Roberti, Maria P.
Fidelle, Marine
Flament, Caroline
Poirier-Colame, Vichnou
Opolon, Paule
Klein, Christophe
Iribarren, Kristina
Mondragon, Laura
Jacquelot, Nicolas
Qu, Bo
Ferrere, Gladys
Clemenson, Celine
Mezquita, Laura
Masip, Jordi Remon
Naltet, Charles
Brosseau, Solenn
Kaderbhai, Coureche
Richard, Corentin
Rizvi, Hira
Levenez, Florence
Galleron, Nathalie
Quinquis, Benoit
Pons, Nicolas
Ryffel, Bernhard
Minard-Colin, Veronique
Gonin, Patrick
Soria, Jean-Charles
Deutsch, Eric
Loriot, Yohann
Ghiringhelli, Francois
Zalcman, Gerard
Goldwasser, Francois
Escudier, Bernard
Hellmann, Matthew D.
Eggermont, Alexander
Raoult, Didier
Albiges, Laurence
Kroemer, Guido
Zitvogel, Laurence
[J]. SCIENCE, 2018, 359 (6371) : 91 - +
[12] Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy-induced colitis
Sakurai, Toshiharu
De Velasco, Marco A.
Sakai, Kazuko
Nagai, Tomoyuki
Nishiyama, Hiroki
Hashimoto, Kentaro
Uemura, Hirotsugu
Kawakami, Hisato
Nakagawa, Kazuhiko
Ogata, Hiroyuki
Nishio, Kazuto
Kudo, Masatoshi
[J]. MOLECULAR ONCOLOGY, 2022, 16 (07) : 1493 - 1507
[13] Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
Shankar, Bairavi
Zhang, Jiajia
Naqash, Abdul Rafeh
Forde, Patrick M.
Feliciano, Josephine L.
Marrone, Kristen A.
Ettinger, David S.
Hann, Christine L.
Brahmer, Julie R.
Ricciuti, Biagio
Owen, Dwight
Toi, Yukihiro
Walker, Paul
Otterson, Gregory A.
Patel, Sandip H.
Sugawara, Shunichi
Naidoo, Jarushka
[J]. JAMA ONCOLOGY, 2020, 6 (12) : 1952 - 1956
[14] Lower Survival in Patients Who Develop Pneumonitis Following Immunotherapy for Lung Cancer
Suresh, Karthik
Naidoo, Jarushka
[J]. CLINICAL LUNG CANCER, 2020, 21 (03) : E169 - E170
[15] Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease A Cohort Study
van der Kooij, Monique K.
Suijkerbuijk, Karijn P. M.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
Blank, Christian U.
Boers-Sonderen, Marye J.
van Breeschoten, Jesper
van den Eertwegh, Alfonsus J. M.
de Groot, Jan Willem B.
Haanen, John B. A. G.
Hospers, Geke A. P.
Piersma, Djura
van Rijn, Rozemarijn S.
Ten Tije, Albert J.
van der Veldt, Astrid A. M.
Vreugdenhil, Gerard
van Zeijl, Michiel C. T.
Wouters, Michel W. J. M.
Dekkers, Olaf M.
Kapiteijn, Ellen
[J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (05) : 641 - +
[16] Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
Wang, Daniel Y.
Salem, Joe-Elie
Cohen, Justine V.
Chandra, Sunandana
Menzer, Christian
Ye, Fei
Zhao, Shilin
Das, Satya
Beckermann, Kathryn E.
Ha, Lisa
Rathmell, W. Kimryn
Ancell, Kristin K.
Balko, Justin M.
Bowman, Caitlin
Davis, Elizabeth J.
Chism, David D.
Horn, Leora
Long, Georgina V.
Carlino, Matteo S.
Lebrun-Vignes, Benedicte
Eroglu, Zeynep
Hassel, Jessica C.
Menzies, Alexander M.
Sosman, Jeffrey A.
Sullivan, Ryan J.
Moslehi, Javid J.
Johnson, Douglas B.
[J]. JAMA ONCOLOGY, 2018, 4 (12) : 1721 - 1728
[17] Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade
Wang, Feng
Yin, Qian
Chen, Liang
Davis, Mark M.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (01) : 157 - 161
[18] Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Wang, Yinghong
Wiesnoski, Diana H.
Helmink, Beth A.
Gopalakrishnan, Vancheswaran
Choi, Kati
DuPont, Hebert L.
Jiang, Zhi-Dong
Abu-Sbeih, Hamzah
Sanchez, Christopher A.
Chang, Chia-Chi
Parra, Edwin R.
Francisco-Cruz, Alejandro
Raju, Gottumukkala S.
Stroehlein, John R.
Campbell, Matthew T.
Gao, Jianjun
Subudhi, Sumit K.
Maru, Dipen M.
Blando, Jorge M.
Lazar, Alexander J.
Allison, James P.
Sharma, Padmanee
Tetzlaff, Michael T.
Wargo, Jennifer A.
Jenq, Robert R.
[J]. NATURE MEDICINE, 2018, 24 (12) : 1804 - +
[19] Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
Weber, Jeffrey S.
Hodi, F. Stephen
Wolchok, Jedd D.
Topalian, Suzanne L.
Schadendorf, Dirk
Larkin, James
Sznol, Mario
Long, Georgina V.
Li, Hewei
Waxman, Ian M.
Jiang, Joel
Robert, Caroline
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 785 - +
[20] A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitors-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Wei, Spencer C.
Meijers, Wouter C.
Axelrod, Margaret L.
Anang, Nana-Ama A. S.
Screever, Elles M.
Wescott, Elizabeth C.
Johnson, Douglas B.
Whitley, Elizabeth
Lehmann, Lorenz
Courand, Pierre-Yves
Mancuso, James J.
Himmel, Lauren E.
Lebrun-Vignes, Benedicte
Wleklinski, Matthew J.
Knollmann, Bjorn C.
Srinivasan, Jayashree
Li, Yu
Atolagbe, Oluwatomisin T.
Rao, Xiayu
Zhao, Yang
Wang, Jing
Ehrlich, Lauren I. R.
Sharma, Padmanee
Salem, Joe-Elie
Balko, Justin M.
Moslehi, Javid J.
Allison, James P.
[J]. CANCER DISCOVERY, 2021, 11 (03) : 614 - 625

← 1 2 →